chr20-16748403-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 8P and 16B. PVS1BP6_Very_StrongBS1BS2
The NM_020157.4(OTOR):āc.2T>Cā(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.0392 in 1,602,702 control chromosomes in the GnomAD database, including 1,395 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.032 ( 101 hom., cov: 32)
Exomes š: 0.040 ( 1294 hom. )
Consequence
OTOR
NM_020157.4 start_lost
NM_020157.4 start_lost
Scores
7
8
Clinical Significance
Conservation
PhyloP100: 5.17
Genes affected
OTOR (HGNC:8517): (otoraplin) This gene encodes a member of the melanoma-inhibiting activity gene family. The encoded protein is secreted via the Golgi apparatus and may function in cartilage development and maintenance. A frequent polymorphism in the translation start codon of this gene can abolish translation and may be associated with forms of deafness. [provided by RefSeq, Jul 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
PVS1
Start lost variant, no new inframe start found.
BP6
Variant 20-16748403-T-C is Benign according to our data. Variant chr20-16748403-T-C is described in ClinVar as [Benign]. Clinvar id is 403282.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-16748403-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0319 (4852/152252) while in subpopulation NFE AF= 0.0447 (3037/68012). AF 95% confidence interval is 0.0433. There are 101 homozygotes in gnomad4. There are 2409 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 101 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTOR | NM_020157.4 | c.2T>C | p.Met1? | start_lost | 1/4 | ENST00000246081.3 | |
OTOR | XM_017027959.3 | c.2T>C | p.Met1? | start_lost | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTOR | ENST00000246081.3 | c.2T>C | p.Met1? | start_lost | 1/4 | 1 | NM_020157.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0319 AC: 4854AN: 152134Hom.: 101 Cov.: 32
GnomAD3 genomes
AF:
AC:
4854
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0348 AC: 8743AN: 251144Hom.: 191 AF XY: 0.0358 AC XY: 4857AN XY: 135716
GnomAD3 exomes
AF:
AC:
8743
AN:
251144
Hom.:
AF XY:
AC XY:
4857
AN XY:
135716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0399 AC: 57945AN: 1450450Hom.: 1294 Cov.: 28 AF XY: 0.0403 AC XY: 29086AN XY: 722410
GnomAD4 exome
AF:
AC:
57945
AN:
1450450
Hom.:
Cov.:
28
AF XY:
AC XY:
29086
AN XY:
722410
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0319 AC: 4852AN: 152252Hom.: 101 Cov.: 32 AF XY: 0.0324 AC XY: 2409AN XY: 74454
GnomAD4 genome
AF:
AC:
4852
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
2409
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
164
ALSPAC
AF:
AC:
169
ESP6500AA
AF:
AC:
40
ESP6500EA
AF:
AC:
390
ExAC
AF:
AC:
4269
Asia WGS
AF:
AC:
41
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency in ESP (all):430/13006=3.3% - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationTaster
Benign
D
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
P
Vest4
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at